TRUFILL
Total Payments
$5.2M
Transactions
3,042
Doctors
624
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 1,065 | 296 |
| 2023 | $1.9M | 696 | 162 |
| 2022 | $1.2M | 411 | 153 |
| 2021 | $233,996 | 181 | 95 |
| 2020 | $27,000 | 80 | 47 |
| 2019 | $54,371 | 73 | 38 |
| 2018 | $60,737 | 315 | 51 |
| 2017 | $58,651 | 221 | 59 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.4M | 810 | 83.1% |
| Consulting Fee | $465,253 | 111 | 8.9% |
| Space rental or facility fees (teaching hospital only) | $247,875 | 12 | 4.7% |
| Travel and Lodging | $94,894 | 312 | 1.8% |
| Food and Beverage | $79,059 | 1,797 | 1.5% |
Payments by Type
Research
$4.4M
810 transactions
General
$887,080
2,232 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multi-Center, Randomized Controlled Pivotal Study to Evaluate the Safety and Effectiveness of TRUFILLn-BCAEmbolization of the Middle Meningeal Arteryfor the Treatment of Subdural Hematoma | Medical Device Business Services, Inc. | $3.7M | 0 |
| A Prospective, Multi-Center, Randomized Controlled Pivotal Study to Evaluate the Safety and Effectiveness of TRUFILL?n-BCAEmbolization of the Middle Meningeal Arteryfor the Treatment of Subdural Hematoma | Medical Device Business Services, Inc. | $537,997 | 0 |
| Outcomes of Embolization with TRUFILL n-butyl-2-cyanoacrylate (n-BCA) Liquid Embolic for Gastrointestinal Bleeds (GIB) | Medical Device Business Services, Inc. | $150,301 | 0 |
Top Doctors Receiving Payments for TRUFILL — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurological Surgery | New York, NY | $496.69 | 9 |
| , MD | Neurocritical Care | Los Angeles, CA | $477.26 | 5 |
| , M.D | Diagnostic Radiology | Los Angeles, CA | $466.46 | 5 |
| , MD | Neurological Surgery | Madison, WI | $460.18 | 4 |
| , M.D | Hematology & Oncology | Cary, NC | $457.52 | 1 |
| , APRN | Nurse Practitioner | Tucson, AZ | $453.80 | 24 |
| , MD | Neurological Surgery | Honolulu, HI | $450.98 | 5 |
| , M.D | Neurological Surgery | Los Angeles, CA | $439.69 | 6 |
| , MD | Neuroradiology | Miami, FL | $438.09 | 7 |
| , MD | Neuroradiology | Albuquerque, NM | $431.33 | 7 |
| , M.D., PH.D | Diagnostic Radiology | Pensacola, FL | $418.05 | 5 |
| , M.D | Neurological Surgery | South Miami, FL | $383.77 | 7 |
| , MD | Neurological Surgery | Birmingham, AL | $382.08 | 10 |
| , M.D | Diagnostic Radiology | Mesa, AZ | $381.57 | 16 |
| , MD | Neurological Surgery | Pennington, NJ | $371.26 | 4 |
| , MD | Student in an Organized Health Care Education/Training Program | New Orleans, LA | $371.26 | 4 |
| , M.D | Neurology | Los Angeles, CA | $365.43 | 6 |
| , MD, PHD | Neurological Surgery | Durham, NC | $360.08 | 4 |
| , MD | Neurology | Syracuse, NY | $350.86 | 4 |
| , MD | Vascular Neurology | Fullerton, CA | $339.23 | 5 |
| , MD | Neurology | Pomona, CA | $338.43 | 6 |
| , M.D | Diagnostic Radiology | Saint Louis, MO | $336.97 | 4 |
| , M.D | Neurological Surgery | Pasadena, CA | $318.79 | 2 |
| , MD | Vascular & Interventional Radiology | San Diego, CA | $310.64 | 1 |
| , MD | Vascular Neurology | San Antonio, TX | $309.30 | 2 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $5.2M
- Total Doctors 624
- Transactions 3,042
About TRUFILL
TRUFILL is a device associated with $5.2M in payments to 624 healthcare providers, recorded across 3,042 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 1,065 transactions to 296 doctors.
The most common payment nature for TRUFILL is "Unspecified" ($4.4M, 83.1% of total).
TRUFILL is associated with 3 research studies, including "A Prospective, Multi-Center, Randomized Controlled Pivotal Study to Evaluate the Safety and Effectiveness of TRUFILLn-BCAEmbolization of the Middle Meningeal Arteryfor the Treatment of Subdural Hematoma" ($3.7M).